AnswersNow Competitive Intelligence & Landscape
getanswersnow.com ·
Overview
AnswersNow Overview
With a workforce of around 102 employees and a recent funding round of $40 million in 2026, AnswersNow has experienced significant growth, expanding its team by 33% annually. The company's mission is to empower families and individuals with autism by providing flexible, accessible, and effective support, ultimately aiming to broaden opportunities for those on the spectrum (growjo.com). Its target market includes families seeking virtual autism therapy, healthcare providers, and insurance companies, positioning itself as a leader in telemedicine and autism support services (getanswersnow.com).
Sources
AnswersNow - Virtual ABA Therapy - Get Started Today
getanswersnow.com
AnswersNow: Revenue, Competitors, Alternatives
growjo.com
AnswersNow
cz.linkedin.com
Answers-Now - Get Your Questions Answered Today
answers-now.com
answers research
answersresearch.com
24/7 Phoenix Live Answering Service - AnswernowInc
answernowinc.com
AnswersNow Weekly Intel Updates
Receive weekly intel updates about AnswersNow straight to your inbox.
Competitors
AnswersNow Competitors
America World Adoption operates primarily in the adoption and family services space, offering support for international and domestic adoptions. Its market positioning is centered on family-centered care and comprehensive adoption services. Unlike AnswersNow, which provides behavioral health therapy, America World Adoption focuses on family integration and post-adoption support, with a pricing model tailored to long-term family services rather than direct therapy sessions (Growjo). Its market share is significant in the adoption sector but less directly competitive.
Northern Virginia Family Service (NVFS) provides a wide range of social services including mental health, housing, and family support. Its key differentiator is its extensive service network and community integration efforts, making it a broad-based social services provider. Compared to AnswersNow, NVFS offers more comprehensive, in-person services across multiple domains, whereas AnswersNow specializes in telehealth behavioral therapy, giving it a competitive edge in digital service delivery and scalability (Growjo).
In terms of market positioning, AnswersNow stands out with its focus on telehealth behavioral therapy, leveraging technology to reach a wider audience at potentially lower costs. While competitors like Roads to Recovery and NVFS focus on in-person and community-based services, AnswersNow’s digital-first approach allows for greater scalability and accessibility, especially in underserved areas. Pricing strategies vary, with AnswersNow offering subscription-based telehealth services, positioning itself competitively in the digital health market (Growjo). Overall, AnswersNow's market share is growing as telehealth adoption increases, but it faces competition from established social service providers expanding into digital solutions.
Sources
AnswersNow: Revenue, Competitors, Alternatives - Growjo
growjo.com
How Do You Stack Up? Competitor Analysis - Boston Digital
bostondigital.com
Competitor Analysis Framework: The 5 Step Guide You MUST Follow
youtube.com
How Much Does ABA Therapy Cost in 2026? Averages & Tips
abcachieve.com
Tilly - 2026 Company Profile, Team & Competitors - Tracxn
tracxn.com
Cost of Competitive Analysis: The Cost of Competitive Analysis: How to Make it Work for You - FasterCapital
fastercapital.com
Competitive Analysis: How to Analyze Your Competitors and Gain a Competitive Edge - FasterCapital
fastercapital.com
Conducting A Competitor Analysis - FasterCapital
fastercapital.com
Product & Pricing
AnswersNow Product and Pricing Intelligence
Recent updates indicate that the platform continues to emphasize affordability and accessibility, with a focus on AI-powered research tools. The pricing structure has been designed to encourage annual subscriptions with a 40% savings, and the free tier remains available for passionate researchers and enterprise users (AnswerThis Pricing).
Overall, AnswersNow's product offerings balance free access to essential research tools with a paid tier that unlocks advanced features, supporting both individual and team-based research needs in a cost-effective manner.
Sources
AnswerThis Pricing
answerthis.io
AnswersNow - Help - Getting Started
business.cch.com
AnswersNow Email Format
rocketreach.co
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
globenewswire.com
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
rss.globenewswire.com
Invest In AnswersNow Stock | Buy Pre-IPO Shares | EquityZen
equityzen.com
Ad Campaigns
AnswersNow Ad Campaigns
AnswersNow is currently running 36 ads across Google — 36 on Google. Explore AnswersNow's live ad creative, messaging, and the platforms they advertise on in the ad library — updated automatically by ForesightIQ.
See of AnswersNow's ads
Browse the live creative across Google, Meta & LinkedIn in the ad library
Hiring & Layoffs
AnswersNow Hiring and Layoffs
In contrast, the broader tech industry is experiencing significant layoffs driven by AI and automation investments. For instance, Dell Technologies announced it would cut 11,000 jobs in 2026 as part of a strategic shift towards AI spending and efficiency improvements (laffaz). Similarly, Atlassian laid off approximately 10% of its workforce (around 1,600 employees) in March 2026, citing the need to adapt to AI-driven changes and to fund further investments in AI and enterprise sales (thenextweb). These layoffs reflect a broader industry trend where companies are restructuring to prioritize AI, often resulting in workforce reductions but also in strategic hiring in specialized AI roles (opentools.ai).
Meanwhile, OpenAI stands out with its aggressive hiring strategy, planning to nearly double its workforce from 4,500 to 8,000 employees by the end of 2026. This expansion, involving over 3,500 new jobs, is driven by competition with firms like Anthropic and aims to accelerate AI product development and enterprise adoption (metaintro). This hiring surge signals a strategic focus on growth and innovation in AI, contrasting with the layoffs seen elsewhere in the tech sector (technoingg). Overall, AnswersNow’s growth pattern indicates a focus on expanding specialized services through technological innovation, while broader industry trends show a mix of layoffs and aggressive hiring in AI to reshape company strategies.
Sources
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
rss.globenewswire.com
OpenAI hiring while everyone else fires: 8,000-employee bet comes amid Anthropic challenge
technoingg.com
Dell cuts 11,000 jobs as AI spending rises — inside the Big Tech layoff playbook - LAFFAZ
laffaz.com
Atlassian is cutting 1,600 jobs and replacing its CTO
thenextweb.com
Global Tech Layoffs Surge as AI Restructuring Dominates Early 2026 | AI News
opentools.ai
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
globenewswire.com
Oracle Layoffs 2026 Explained in Full Detail — Insight Crunch
insightcrunch.com
3,500 New Jobs in 9 Months: Inside OpenAI's... | Metaintro
metaintro.com
Leadership
AnswersNow Management and Leadership Team
Jeff Beck, a co-founder, has been leading the company since its inception in 2016 and has a background in social work, emphasizing accessibility and clinical care (Jeff Beck profile). Morry Belkin, appointed as CTO in early 2026, brings extensive experience in technology leadership, with a background from Carnegie Mellon University (Equilar).
Recent leadership developments include the appointment of Morry Belkin as CTO in 2026, reflecting the company's focus on technological innovation. The company also announced the launch of a corporate advisory board in mid-2025 to support its growth and scaling efforts (Recent news). Overall, AnswersNow's leadership is focused on advancing its mission to provide accessible, evidence-based autism therapy through innovative virtual platforms.
Sources
Leadership Team - AnswersNow - The Org
theorg.com
Jeff Beck, LCSW - Co-Founder at AnswersNow - LinkedIn
linkedin.com
AnswersNow - LinkedIn
linkedin.com
AnswersNow - 2026 Company Profile, Team, Funding & Competitors - Tracxn
tracxn.com
Answersnow - Phone, Email, Employees, CEO, VP, 2024
visualvisitor.com
Morry Belkin - Executive Bio, Work History, and Contacts - Equilar ExecAtlas
people.equilar.com
Financials
AnswersNow Financial Performance, Fundraising, M&A
Sources
AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI ...
finance.yahoo.com
AnswersNow Secures $40M to Disrupt Broken Autism Support ...
hitconsultant.net
AnswersNow - 2026 Company Profile, Team, Funding & Competitors
tracxn.com
AnswersNow Raises $40M, Plans to Double Clinician Headcount
bhbusiness.com
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
globenewswire.com
AnswersNow - 2026 Company Profile, Team, Funding & Competitors - Tracxn
tracxn.com
AnswersNow Company Information - Funding, Investors, and More
staging.seedtable.com
Partnerships
AnswersNow Partnerships, Clients and Vendors
In 2026, AnswersNow secured its largest funding round to date, raising $40 million led by HealthQuest Capital, with participation from existing investors such as Left Lane Capital and Owl Ventures. This capital will enable AnswersNow to scale its AI-driven autism therapy model, doubling its clinical staff and expanding its service offerings (BriefGlance.com). Their recent funding success underscores their ecosystem's strength and investor confidence in their innovative approach (grpva.com).
Furthermore, AnswersNow maintains strategic relationships with key industry players and is actively expanding its ecosystem through partnerships and integrations. Their collaboration with ServiceNow, for example, involves leveraging the Now Platform to power their internal operations and training centers, further embedding them within a broader digital ecosystem (servicenow.com). These ecosystem relationships enable AnswersNow to enhance its technological capabilities and extend its reach in the healthcare sector.
Sources
AnswersNow closes biggest capital raise to date | GRPVA.com
grpva.com
AnswersNow Lands $40M to Scale AI-Driven Autism Therapy Model - BriefGlance.com
briefglance.com
AnswersNow - Virtual ABA Therapy - Get Started Today
getanswersnow.com
AnswersNow aims to scale nationwide to deliver ABA Therapy with ...
gethealthie.com
ServiceNow announces strategic partnership with ANSR to power global capability centers on the Now Platform - ServiceNow Newsroom
newsroom.servicenow.com
ANDREW MELLOW - Director of Partnerships at AnswersNow | The Org
theorg.com
Events
AnswersNow Event Participations
Sources
AnswersNow Raises $40M Series B to Scale AI-Enabled, BCBA-Led ...
hlth.com
Answer.AI Event Detail
answerai.pro
AnswersNow - Virtual ABA Therapy - Get Started Today
getanswersnow.com
For BCBAs - AnswersNow
getanswersnow.com
AnswersNow (@getanswersnow) - Facebook
facebook.com
AnswersNow Completes $40M Series B to Expand BCBA-Driven,
globenewswire.com
AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI-Enabled Autism Therapy
vcaonline.com
Frequently Asked Questions
What does AnswersNow's decision to double clinical staff following its $40M Series B signal about where it sees its growth constraint?
AnswersNow is signaling that its primary bottleneck is BCBA (Board Certified Behavior Analyst) capacity, not technology or capital. The January 2026 Series B, led by HealthQuest Capital with participation from Left Lane Capital and Owl Ventures, is explicitly earmarked for doubling clinical staff alongside expanding service offerings — suggesting the company believes it has validated its virtual ABA model and is now in a supply-scaling phase rather than a product-discovery phase.
What does AnswersNow's 33% annual headcount growth rate, against a current base of roughly 102 employees, imply about its operational maturity ahead of a potential exit or Series C?
At roughly 102 employees growing 33% annually, AnswersNow is still in an early scaling stage where the organization is not yet large enough to have the operational redundancy or management layers typical of a Series C or pre-exit company. The simultaneous appointment of a CTO (Morry Belkin, early 2026) and the launch of a corporate advisory board (mid-2025) suggest leadership is actively building institutional infrastructure to match its capital raise, but the company is likely 18–36 months away from the organizational maturity that would support a large strategic transaction.
What does the appointment of Morry Belkin as CTO in early 2026 signal about AnswersNow's product direction?
Bringing in a dedicated CTO immediately after closing a $40M Series B strongly signals that AnswersNow is transitioning from a clinically led, tech-enabled model to one where AI and platform architecture are first-order strategic priorities. Prior to Belkin's appointment, the CTO role was either vacant or not publicly prominent; adding it now, alongside a Chief Product Officer (Jennifer Grasso) and a Chief Research Officer (Brittany Wierzba), indicates the company is assembling a product and engineering leadership layer capable of building proprietary AI systems rather than relying solely on third-party infrastructure.
What does AnswersNow's 2021 partnership with Healthie reveal about its build-vs-buy philosophy, and has that philosophy shifted?
The 2021 Healthie partnership — in which AnswersNow adopted Healthie's API to power scheduling, coaching, and clinical management — indicates that early on the company chose to buy or partner for core infrastructure rather than build it. The 2026 CTO hire and the framing of the Series B around AI-enabled therapy suggest the company is now shifting toward building more proprietary technology in-house, consistent with a maturation path where differentiated IP becomes critical for defensibility and valuation.
What does AnswersNow's insurance coverage positioning — accepting all major carriers including Medicaid — signal about its go-to-market strategy versus typical telehealth startups?
Accepting Medicaid alongside commercial insurance is a deliberate under-served-market play that most venture-backed telehealth startups avoid due to lower reimbursement rates and administrative complexity. This positions AnswersNow to capture demand in lower-income and rural populations where autism waitlists are longest, giving it a volume and mission-driven narrative that is attractive to healthcare-focused investors like HealthQuest Capital while also creating a competitive moat that pure-premium-market competitors cannot easily replicate.
Is AnswersNow's financial trajectory a credible growth story or does the gap between its ~$1–1.2M 2018 revenue estimate and its 2026 $40M raise raise red flags about capital efficiency?
The 2018 revenue estimate of $1–1.2M is now roughly eight years old and should not be used as a reliable current revenue proxy; the company has since raised a $40M Series B with participation from institutional healthcare investors including HealthQuest Capital and Left Lane Capital, which implies materially higher current revenue was underwriting that valuation. That said, the absence of disclosed current revenue figures means analysts cannot independently verify capital efficiency or unit economics — a gap that ForesightIQ flags as a key diligence item for any corp-dev or partnership conversation.
What does the composition of AnswersNow's Series B investor syndicate — HealthQuest Capital, Left Lane Capital, Owl Ventures — signal about how the company is being positioned strategically?
The syndicate blends a pure healthcare growth equity firm (HealthQuest Capital) with a consumer-internet-scale investor (Left Lane Capital) and an edtech/learning-focused fund (Owl Ventures), which suggests AnswersNow is being underwritten simultaneously as a clinical-outcomes business, a consumer subscription platform, and a tech-enabled learning service. This multi-frame investor base indicates the company is positioning itself at the intersection of healthcare services and consumer technology — a broader TAM story than pure clinical ABA — and likely complicates a clean strategic acquirer profile, since it fits healthcare services, edtech, and consumer health roll-up theses equally.
What does AnswersNow's competitive set — Roads to Recovery, NVFS, America World Adoption — reveal about where it actually faces market pressure versus where the real competitive threat originates?
The listed competitors are primarily community-based, in-person social service providers rather than direct telehealth ABA rivals, which suggests AnswersNow's most immediate competitive displacement is against legacy local providers rather than against venture-backed digital health peers. The more strategically relevant competitive threat — not fully captured in current profiling — likely comes from other VC-backed tele-ABA platforms and from large ABA provider networks that are adding telehealth capabilities; the current competitive framing may understate the intensity of competition at the payor and employer-benefit level.
What does AnswersNow's announcement of a corporate advisory board in mid-2025 signal about its near-term strategic priorities?
Launching a corporate advisory board roughly six months before closing a $40M Series B is a classic pre-raise credentialing move, designed to add domain expertise, network access, and institutional legitimacy to support both the fundraise and subsequent scaling. It signals that AnswersNow's leadership recognized gaps — likely in payor relations, enterprise sales, or regulatory navigation — that the existing executive team could not fill organically, and that the company is preparing for a more complex operating environment post-raise.
What does AnswersNow's presence at the HLTH conference to announce its Series B signal about its investor relations and business development strategy?
Choosing HLTH — one of the highest-profile health innovation conferences in the U.S. — as the venue to announce the $40M Series B indicates that AnswersNow is actively targeting visibility among health system executives, payor decision-makers, and strategic acquirers, not just the venture community. This is a business development signal as much as a PR one: the company is using the raise announcement to open doors with potential enterprise and payor partners who attend HLTH, consistent with a strategy of moving from a direct-to-consumer acquisition model toward B2B2C distribution through health plans and employers.
What does the structure of AnswersNow's leadership team — with distinct Chief Science, Chief Research, and Chief Product Officer roles — suggest about internal tensions or strategic alignment challenges?
Having separate CSO (Adam Dreyfus), Chief Research Officer (Brittany Wierzba), and Chief Product Officer (Jennifer Grasso) roles at a ~102-person company indicates a deliberate effort to keep clinical science and evidence generation organizationally distinct from commercial product development — a structure common in clinical-stage companies that want to protect research credibility while accelerating product velocity. The potential tension is that three senior leaders with overlapping scopes (science, research, product) at this company size can create coordination friction; how well CEO Jeff Beck arbitrates that tension will be a key operational risk factor as the company scales toward doubling clinical headcount.
Powered by ForesightIQ · Competitive intelligence from digital exhaust